19 May 2013
Keywords: phoqus, and/diurnal, chronocort, enters, ph, uk-based, oral
Article | 12 December 2005
Phoqus, a UK-based oral drug-delivery company, and Diurnal, a spin-out from the UK's Sheffied University, have begun Phase I clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 December 2005
17 May 2013
© 2013 thepharmaletter.com